Clinical Trials Directory

Trials / Completed

CompletedNCT01203904

Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation

Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation for Long Term Use in Pediatrics

Status
Completed
Phase
Study type
Observational
Enrollment
301 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to confirm the safety profile for long term treatment in children aged 5 years and \<15 years on bronchial asthma in daily clinical usage/Effect on growth rate. Effect on adrenal function. Development of infection diseases by diseases type.

Conditions

Timeline

Start date
2010-09-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2010-09-17
Last updated
2016-06-07

Locations

37 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT01203904. Inclusion in this directory is not an endorsement.

Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation (NCT01203904) · Clinical Trials Directory